Literature DB >> 18794666

A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder.

Andrea H Weinberger, Jennifer C Vessicchio, Kristi A Sacco, Cerissa L Creeden, K N Roy Chengappa, Tony P George.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18794666      PMCID： PMC3684621          DOI： 10.1097/JCP.0b013e318184ba3c

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  16 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder.

Authors:  Michael J Ostacher; Andrew A Nierenberg; Roy H Perlis; Polina Eidelman; David J Borrelli; Tanya B Tran; Gianna Marzilli Ericson; Roger D Weiss; Gary S Sachs
Journal:  J Clin Psychiatry       Date:  2006-12       Impact factor: 4.384

3.  Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.

Authors:  T P George; D M Ziedonis; A Feingold; W T Pepper; C A Satterburg; J Winkel; B J Rounsaville; T R Kosten
Journal:  Am J Psychiatry       Date:  2000-11       Impact factor: 18.112

4.  Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program.

Authors:  Jeanette A Waxmonsky; Marshall R Thomas; David J Miklowitz; Michael H Allen; Stephen R Wisniewski; Hongwei Zhang; Michael J Ostacher; Mark D Fossey
Journal:  Gen Hosp Psychiatry       Date:  2005 Sep-Oct       Impact factor: 3.238

5.  The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings.

Authors:  E Mundo; M Walker; T Cate; F Macciardi; J L Kennedy
Journal:  Arch Gen Psychiatry       Date:  2001-06

6.  Smoking and mental illness: A population-based prevalence study.

Authors:  K Lasser; J W Boyd; S Woolhandler; D U Himmelstein; D McCormick; D H Bor
Journal:  JAMA       Date:  2000 Nov 22-29       Impact factor: 56.272

7.  Inhibition of CYP2D6 activity by bupropion.

Authors:  Michael Kotlyar; Lisa H Brauer; Timothy S Tracy; Dorothy K Hatsukami; Jennifer Harris; Carrie A Bronars; David E Adson
Journal:  J Clin Psychopharmacol       Date:  2005-06       Impact factor: 3.153

8.  A placebo controlled trial of bupropion for smoking cessation in schizophrenia.

Authors:  Tony P George; Jennifer C Vessicchio; Angelo Termine; Thomas A Bregartner; Alan Feingold; Bruce J Rounsaville; Thomas R Kosten
Journal:  Biol Psychiatry       Date:  2002-07-01       Impact factor: 13.382

9.  Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant.

Authors:  R T Joffe; G M MacQueen; M Marriott; J Robb; H Begin; L T Young
Journal:  Acta Psychiatr Scand       Date:  2002-06       Impact factor: 6.392

10.  Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study.

Authors:  Roger S McIntyre; Deborah A Mancini; Sonia McCann; Janaki Srinivasan; Doron Sagman; Sidney H Kennedy
Journal:  Bipolar Disord       Date:  2002-06       Impact factor: 6.744
View more
  21 in total

1.  Mood management and nicotine patch for smoking cessation in adults with bipolar disorder.

Authors:  Jaimee L Heffner; Robert M Anthenelli; Melissa P DelBello; Lauren Stahl; Stephen M Strakowski
Journal:  Nicotine Tob Res       Date:  2013-06-12       Impact factor: 4.244

Review 2.  The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations.

Authors:  Jaimee L Heffner; Jeffrey R Strawn; Melissa P DelBello; Stephen M Strakowski; Robert M Anthenelli
Journal:  Bipolar Disord       Date:  2011 Aug-Sep       Impact factor: 6.744

3.  A Review of Smoking Cessation in Bipolar Disorder: Implications for Future Research.

Authors:  Tony P George; Becky S Wu; Andrea H Weinberger
Journal:  J Dual Diagn       Date:  2012-05-11

Review 4.  Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices.

Authors:  A Eden Evins; Corinne Cather; Alexandra Laffer
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

Review 5.  Treatment of tobacco dependence in people with mental health and addictive disorders.

Authors:  Kristen M Mackowick; Marie-Josee Lynch; Andrea H Weinberger; Tony P George
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

6.  "I Smoke Like This to Suppress These Issues That Are Flaws of My Character": Challenges and Facilitators of Cessation Among Smokers With Bipolar Disorder.

Authors:  Jaimee L Heffner; Noreen L Watson; Jennifer B McClure; Robert M Anthenelli; Sarah Hohl; Jonathan B Bricker
Journal:  J Dual Diagn       Date:  2018-01-19

7.  Acceptance and Commitment Therapy and nicotine patch for smokers with bipolar disorder: preliminary evaluation of in-person and telephone-delivered treatment.

Authors:  Jaimee L Heffner; Jennifer B McClure; Kristin E Mull; Robert M Anthenelli; Jonathan B Bricker
Journal:  Bipolar Disord       Date:  2015-04-25       Impact factor: 6.744

Review 8.  Tobacco use treatment in primary care patients with psychiatric illness.

Authors:  Joseph M Cerimele; Abigail C Halperin; Andrew J Saxon
Journal:  J Am Board Fam Med       Date:  2014 May-Jun       Impact factor: 2.657

9.  A Preliminary Feasibility Study of Varenicline for Smoking Cessation in Bipolar Disorder.

Authors:  Becky S Wu; Andrea H Weinberger; Enza Mancuso; Victoria C Wing; Bahar Haji-Khamneh; Andrea J Levinson; Tony P George
Journal:  J Dual Diagn       Date:  2012-03-20

Review 10.  Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.

Authors:  Emmert Roberts; A Eden Evins; Ann McNeill; Debbie Robson
Journal:  Addiction       Date:  2016-01-19       Impact factor: 6.526
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.